The DOI matches its Crossref record; 111 of the 112 references it cites were found in a registry or an index.
Brain stress systems in the amygdala and addiction
Open accessAbstract
Dysregulation of the brain emotional systems that mediate arousal and stress is a key component of the pathophysiology of drug addiction. Drug addiction is a chronically relapsing disorder characterized by a compulsion to seek and take drugs and the development of dependence and manifestation of a negative emotional state when the drug is removed. Activation of brain stress systems is hypothesized to be a key element of the negative emotional state produced by dependence that drives drug-seeking through negative reinforcement mechanisms. The focus of the present review is on the role of two key brain arousal/stress systems in the development of dependence. Emphasis is placed on the neuropharmacological actions of corticotropin-releasing factor (CRF) and norepinephrine in extrahypothalamic systems in the extended amygdala, including the central nucleus of the amygdala, bed nucleus of the stria terminalis, and a transition area in the shell of the nucleus accumbens. Compelling evidence argues that these brain stress systems, a heretofore largely neglected component of dependence and addiction, play a key role in engaging the transition to dependence and maintaining dependence once it is initiated. Understanding the role of the brain stress and anti-stress systems in addiction not only provides insight into the neurobiology of the "dark side" of addiction but also provides insight into the organization and function of basic brain emotional circuitry that guides motivated behavior.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The distress and negative emotions of withdrawal are associated on the one hand with reduced dopamine signaling in response to rewards (anhedonia) and on the other with an enhanced sensitiv ity of the brain's stress system, including the extended amygdala, habenula and hypothalamus 66 .”
From Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention (2023) · cites this paper as [66]
Experimental — accuracy not yet measuredIn the citing paper
“Recruitment of brain stress amygdale activation has been suggested to cause the negative motivational state that drives addicitoin (Koob, 2009).”
From Impulsivity, frontal lobes and risk for addiction (2009) · cites this paper as Koob, 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
A Syndrome produced by Diverse Nocuous Agents
Selye, H. (1936) · Nature · doi:10.1038/138032a0 · Cited by 3,967
Drug Addiction, Dysregulation of Reward, and Allostasis
Koob, G. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00195-0 · Cited by 2,953
Self-citationDrug abuse: hedonic homeostatic dysregulation
Koob, G. F., & Moal, M. L. (1997) · Science · doi:10.1126/science.278.5335.52 · Cited by 2,535
Self-citationSwanson, L. W., Sawchenko, P. E., Rivier, J., & Vale, W. W. (2008) · Neuroendocrinology · doi:10.1159/000123454 · Cited by 1,953
The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress
Smith, S. M., & Vale, W. W. (2006) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2006.8.4/ssmith · Cited by 1,948
The reinstatement model of drug relapse: history, methodology and major findings
Shaham, Y., Shalev, U., Lu, L., de Wit, H., & Stewart, J. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1224-x · Cited by 1,615
Addiction and the brain antireward system
Koob, G. F., & Le Moal, M. (2008) · Annual Review of Psychology · doi:10.1146/annurev.psych.59.103006.093548 · Cited by 1,457
Self-citationAllostasis: A New Paradigm to Explain Arousal Pathology
Sterling, P., & Eyer, J. (1988) · Zenodo · doi:10.5281/zenodo.13537700 · Cited by 1,450
Handbook of Life Stress, Cognition and Health
PASTOR, L. H. (1989) · American Journal of Psychiatry · doi:10.1176/ajp.146.10.1347 · Cited by 1,402
Cited by
Sorted by citations
Items 101–200 of 389
Kokare, D. M., Kyzar, E. J., Zhang, H., Sakharkar, A. J., & Pandey, S. C. (2017) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx041 · Cited by 54
Pogorelov, V. M., Nomura, J., Kim, J., Kannan, G., Ayhan, Y., Yang, C., Taniguchi, Y., Abazyan, B. N., Valentine, H., Krasnova, I. N., et al. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.02.003 · Cited by 52
The centrally projecting Edinger–Westphal nucleus—I: Efferents in the rat brain
Júnior, E. D. D. S., da Silva, A. V., Silva, K. R. T. D., Haemmerle, C. A. D. S., Battagello, D. S., da Silva, J. M., Lima, L. B., Silva, R. J. D., Diniz, G. B., Sita, L. V., et al. (2015) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2015.07.002 · Cited by 50
Chang, G., Karatayev, O., & LEIBOWITZ, S. F. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.5835-12.2013 · Cited by 50
Belujon, P., Jakobowski, N. L., Dollish, H. K., & Grace, A. A. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.191 · Cited by 52
Wilcox, C. E., Tonigan, J. S., Bogenschutz, M. P., Clifford, J. M., Bigelow, R., & Simpson, T. L. (2018) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000413 · Cited by 49
Stopponi, S., Fotio, Y., Domi, A., Borruto, A. M., Natividad, L., Roberto, M., Ciccocioppo, R., & Cannella, N. (2018) · Addiction Biology · doi:10.1111/adb.12573 · Cited by 48
Acevedo, M. B., Fabio, M. C., Fernández, M. S., & Pautassi, R. M. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.08.011 · Cited by 48
Martz, M. E., Hart, T., Heitzeg, M. M., & Peltier, S. (2020) · NeuroImage Clinical · doi:10.1016/j.nicl.2020.102350 · Cited by 56
Stress, epigenetics, and alcoholism
Moonat, S. (2012) · Alcohol research · doi:10.35946/arcr.v34.4.13 · Cited by 46
Fox, H. C., & Sinha, R. (2014) · Advances in pharmacology · doi:10.1016/b978-0-12-420118-7.00006-8 · Cited by 46
Laboratory-induced stress and craving among individuals with prescription opioid dependence
Back, S. E., Grös, D. F., Price, M., LaRowe, S. D., Flanagan, J. C., Brady, K. T., Davis, C., Jaconis, M., & McCauley, J. L. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.08.019 · Cited by 46
The Corticotropin Releasing Factor Receptor 1 in Alcohol Use Disorder: Still a Valid Drug Target?
Pomrenze, M. B., Fetterly, T. L., Winder, D. G., & Messing, R. O. (2017) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13507 · Cited by 46
McReynolds, J. R., Christianson, J. P., Blacktop, J. M., & Mantsch, J. R. (2018) · Neurobiology of Stress · doi:10.1016/j.ynstr.2018.05.004 · Cited by 49
The affective dimension of pain as a risk factor for drug and alcohol addiction
LeBlanc, D. M., McGinn, M. A., Itoga, C. A., & Edwards, S. (2015) · Alcohol · doi:10.1016/j.alcohol.2015.04.005 · Cited by 44
Morley, K. C., Perry, C. J., Watt, J., Hurzeler, T. P., Leggio, L., Lawrence, A. J., & Haber, P. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1892641 · Cited by 44
Grimm, J. W., Barnes, J. L., Koerber, J., Glueck, E., Ginder, D. E., Hyde, J., & Eaton, L. (2015) · Brain Structure and Function · doi:10.1007/s00429-015-1074-z · Cited by 44
Dao, N. C., Nair, M. S., Magee, S. N., Moyer, J. B., Sendao, V., Brockway, D. F., & Crowley, N. A. (2020) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2020.00086 · Cited by 43
Beckerman, M. A., Kempen, T. A. V., Justice, N. J., Milner, T. A., & Glass, M. J. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.10.009 · Cited by 42
Neural correlates of adherence to extended-release naltrexone pharmacotherapy in heroin dependence
Wang, A. L., Elman, I., Lowen, S. B., Blady, S. J., Lynch, K. G., Hyatt, J. M., O’Brien, C. P., & Langleben, D. D. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.20 · Cited by 41
Pre-clinical models of reward deficiency syndrome: A behavioral octopus
Gondré‐Lewis, M. C., Bassey, R. B., & Blum, K. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.04.021 · Cited by 42
Effect of Chronic Ethanol on Enkephalin in the Hypothalamus and Extra‐Hypothalamic Areas
Chang, G., Barson, J. R., Karatayev, O., Chang, S. Y. A., Chen, Y., & LEIBOWITZ, S. F. (2010) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2010.01148.x · Cited by 44
Verplaetse, T. L., Weinberger, A. H., Smith, P. H., Cosgrove, K., Mineur, Y. S., Picciotto, M. R., Mazure, C. M., & McKee, S. A. (2015) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntu280 · Cited by 41
Fischer 344 and Lewis Rat Strains as a Model of Genetic Vulnerability to Drug Addiction
Cadoni, C. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00013 · Cited by 42
Interaction Between Stress and Addiction: Contributions From Latin-American Neuroscience
Torres‐Berrío, A., Cuesta, S., López-Guzmán, S., & Nava-Mesa, M. O. (2018) · Frontiers in Psychology · doi:10.3389/fpsyg.2018.02639 · Cited by 48
Bidirectional role of acupuncture in the treatment of drug addiction
Lee, M. Y., Lee, B. H., Kim, H. Y., & Yang, C. H. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.04.004 · Cited by 47
Marvel, C. L., Faulkner, M. L., Strain, E. C., Mintzer, M. Z., & Desmond, J. E. (2011) · The Cerebellum · doi:10.1007/s12311-011-0311-0 · Cited by 40
Advances in understanding meso‐cortico‐limbic‐striatal systems mediating risky reward seeking
Piantadosi, P. T., Halladay, L. R., Radke, A. K., & Holmes, A. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15342 · Cited by 45
Kenna, G. A., Swift, R. M., Hillemacher, T., & Leggio, L. (2012) · Neuropsychology Review · doi:10.1007/s11065-012-9209-y · Cited by 38
Harris, N. A., Isaac, A., Günther, A., Merkel, K., Melchior, J. R., Xu, M., Eguakun, E., Perez, R. E., Nabit, B. P., Flavin, S. A., et al. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.0963-18.2018 · Cited by 40
Wille‐Bille, A., de Olmos, S., Marengo, L. G., Chiner, F., & Pautassi, R. M. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.11.008 · Cited by 38
Noradrenergic circuits and signaling in substance use disorders
Downs, A. M., & McElligott, Z. A. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.108997 · Cited by 37
Stress Facilitates the Development of Cognitive Dysfunction After Chronic Ethanol Exposure
Rodberg, E. M., den Hartog, C. R., Anderson, R. I., Becker, H. C., Moorman, D. E., & Vazey, E. M. (2017) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13444 · Cited by 37
Walker, L. C., Kastman, H. E., Krstew, E., Gundlach, A. L., & Lawrence, A. J. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13955 · Cited by 37
Costine, B. A., Oberlander, J. G., Davis, M. C., Penatti, C. A. A., Porter, D. M., Leaton, R. N., & Henderson, L. (2010) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.04.015 · Cited by 37
Cozzoli, D. K., Courson, J. A., Rostock, C., Campbell, R. R., Wroten, M. G., McGregor, H. A., Caruana, A. L., Miller, B. W., Hu, J.-H., Zhang, P. W., et al. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.01.019 · Cited by 36
Problematic drinking and physiological responses among female college students
Wemm, S., Fanean, A. P., Baker, A., Blough, E. R., Mewaldt, S. P., & Bardi, M. (2013) · Alcohol · doi:10.1016/j.alcohol.2012.12.006 · Cited by 37
Matzeu, A., & Martin‐Fardon, R. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107906 · Cited by 36
Stressful Life Events and Relapse Among Formerly Alcohol Dependent Adults
Pilowsky, D. J., Keyes, K. M., Geier, T. J., Grant, B. F., & Hasin, D. S. (2013) · Social Work in Mental Health · doi:10.1080/15332985.2012.711278 · Cited by 35
Lin, X., Wang, Q., Cheng, Y., Ji, J., & Yu, L. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.03.002 · Cited by 32
Wadsley, M. G., & Ihssen, N. (2023) · Brain Sciences · doi:10.3390/brainsci13050787 · Cited by 40
Ruggles, K. V., Fang, Y., Tate, J., Mentor, S. M., BRYANT, K. J., Fiellin, D. A., Justice, A. C., & Braithwaite, R. S. (2016) · AIDS and Behavior · doi:10.1007/s10461-016-1492-9 · Cited by 32
Martí‐Prats, L., Belin‐Rauscent, A., Fouyssac, M., Puaud, M., Cocker, P. J., Everitt, B. J., & Belin, D. (2021) · Addiction Biology · doi:10.1111/adb.13011 · Cited by 31
Stress-induced cross-sensitization to amphetamine is related to changes in the dopaminergic system
Cruz, F. C., Marin, M. T., Leão, R. M., & Planeta, C. S. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-011-0720-8 · Cited by 31
Gondré‐Lewis, M. C., Darius, P. J., Wang, H., & Allard, J. S. (2016) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2016.02.004 · Cited by 33
Kaye, J. T., Bradford, D. E., Magruder, K. P., & Curtin, J. J. (2017) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2017.78.353 · Cited by 29
Liu, F., Jiang, H., Zhong, W., Wu, X., & Luo, J. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.09.052 · Cited by 30
Interaction of cannabinoid receptor 2 and social environment modulates chronic alcohol consumption
Pradier, B., Erxlebe, E., Markert, A., & Rácz, I. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.03.051 · Cited by 30
Lam, M. P., & Gianoulakis, C. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2337-x · Cited by 32
Stefaniuk, M., Pawłowska, M., Barański, M., Nowicka, K., Zieliński, Z., Bijoch, Ł., Legutko, D., Majka, P., Bednarek, S., Jermakow, N., et al. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106006 · Cited by 29
The hypocretin/orexin system as a target for excessive motivation in alcohol use disorders
Moorman, D. E. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4871-2 · Cited by 31
Vaseghi, S., Zarrabian, S., & Haghparast, A. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.104516 · Cited by 29
Tan, X.-J., Dai, Y.-B., Wu, W.-F., Warner, M. N., & Gustafsson, J.-Α. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205189109 · Cited by 29
Estrogen receptor β and Liver X receptor β: biology and therapeutic potential in CNS diseases
Warner, M. N., & Gustafsson, J.-Å. (2014) · Molecular Psychiatry · doi:10.1038/mp.2014.23 · Cited by 30
Perez, C. F., Reguilón, M. D., Manzanedo, C., Aguilar, M. A., Miñarro, J., & Rodríguez‐Arias, M. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.01.052 · Cited by 28
Pleil, K. E., & Skelly, M. J. (2018) · Alcohol · doi:10.1016/j.alcohol.2018.01.007 · Cited by 29
Zhang, K., Lu, J., & Yao, L. (2019) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2019.11.004 · Cited by 27
Factors contributing to the escalation of alcohol consumption
Bowen, M. T., George, O., Muskiewicz, D. E., & Hall, F. S. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.11.017 · Cited by 29
Focus on: Comorbid mental health disorders.
Anthenelli, R. M. (2010) · Europe PMC (PubMed Central) · Cited by 27
Toward a systems-oriented approach to the role of the extended amygdala in adaptive responding
Waraczynski, M. A. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.05.015 · Cited by 28
Berkel, T. D. M., Zhang, H., Teppen, T. L., Sakharkar, A. J., & Pandey, S. C. (2018) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyy102 · Cited by 27
Zheng, H., Law, P., & Loh, H. H. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00113 · Cited by 26
The Neurokinin-1 Receptor in Addictive Processes
Schank, J. R. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.210799 · Cited by 26
Wills, K. L., Petrie, G. N., Millett, G., Limebeer, C. L., Rock, E. M., Niphakis, M. J., Cravatt, B. F., & Parker, L. A. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.356 · Cited by 25
Vanderkam, P., Solinas, M., Ingrand, I., Doux, N., Ebrahimighavam, S., Jaafari, N., & Lafay‐Chebassier, C. (2021) · Addiction · doi:10.1111/add.15265 · Cited by 25
Targeting the Orexin System for Prescription Opioid Use Disorder
Matzeu, A., & Martin‐Fardon, R. (2020) · Brain Sciences · doi:10.3390/brainsci10040226 · Cited by 25
Understanding and Treating Opioid Addiction in a Patient With Cancer Pain
Kircher, S. M., Zacny, J. P., Apfelbaum, S. M., Passik, S. D., Kirsch, K., Burbage, M., & Lofwall, M. R. (2011) · Journal of Pain · doi:10.1016/j.jpain.2011.07.006 · Cited by 25
Kaag, A. M., Reneman, L., Homberg, J. R., van den Brink, W., & van Wingen, G. A. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00070 · Cited by 26
Hemakom, A., Atiwiwat, D., & Israsena, P. (2024) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2024.106379 · Cited by 27
Hoven, M., Schluter, R., Schellekens, A., van Holst, R. V., & Goudriaan, A. (2022) · Addiction · doi:10.1111/add.16025 · Cited by 19
A prospective study of stress and alcohol craving in heavy drinkers
Tartter, M. A., & Ray, L. A. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.03.007 · Cited by 23
Wscieklica, T., Viana, M. D. B., Sueur, L. D. P. L., Pouza, K. C. P., Spadari, R. C., & Céspedes, I. C. (2015) · Alcohol · doi:10.1016/j.alcohol.2015.11.005 · Cited by 23
Harris, N. A., & Winder, D. G. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00169 · Cited by 22
Edalat, P., Kavianpour, M., Zarrabian, S., & Haghparast, A. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.06.016 · Cited by 24
Prefrontal Cortex Functioning of Family Members of Those with a Substance Use Disorder
Shumway, S. T., Bradshaw, S. D., Hayes, N., Schonian, S., & Kimball, T. G. (2018) · Alcoholism Treatment Quarterly · doi:10.1080/07347324.2018.1488549 · Cited by 23
Silberman, Y., & Winder, D. G. (2015) · Alcohol · doi:10.1016/j.alcohol.2015.01.006 · Cited by 24
Role of corticotropin-releasing factor in alcohol and nicotine addiction
Simpson, S., Shankar, K., Kimbrough, A., & George, O. (2020) · Brain Research · doi:10.1016/j.brainres.2020.146850 · Cited by 24
Bidirectional Control of Alcohol-drinking Behaviors Through Locus Coeruleus Optoactivation
Deal, A. L., Bass, C. E., Grinevich, V. P., Delbono, O., Bonin, K., Weiner, J. L., & Budygin, E. A. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.07.024 · Cited by 22
Duka, T., & Stephens, D. (2014) · Current Addiction Reports · doi:10.1007/s40429-013-0009-0 · Cited by 22
Addiction and the adrenal cortex
Vinson, G. P., & Brennan, C. H. (2013) · Endocrine Connections · doi:10.1530/ec-13-0028 · Cited by 25
Zhao, Z., Jin, X., Wu, Y., Yang, X., Xu, Y., Jiang, J. Z., Kim, S. C., Lee, B. H., Yang, C. H., & Zhao, R. (2013) · Journal of Acupuncture and Meridian Studies · doi:10.1016/j.jams.2013.01.017 · Cited by 22
Mohammadian, J., & Miladi‐Gorji, H. (2019) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2019.172793 · Cited by 22
Ross, J. A., & Bockstaele, E. J. V. (2020) · European Journal of Neuroscience · doi:10.1111/ejn.14714 · Cited by 20
Corticolimbic catecholamines in stress: a computational model of the appraisal of controllability
Fiore, V. G., Mannella, F., Mirolli, M., Latagliata, E. C., Valzania, A., Cabib, S., Dolan, R. J., Puglisi‐Allegra, S., & Baldassarre, G. (2014) · Brain Structure and Function · doi:10.1007/s00429-014-0727-7 · Cited by 21
Nona, C. N., Guirguis, S. M. E., & Nobrega, J. N. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.12.035 · Cited by 21
Granholm, L., Todkar, A., Bergman, S., Nilsson, K. W., Comasco, E., & Nylander, I. (2017) · Brain Research · doi:10.1016/j.brainres.2017.05.006 · Cited by 21
Nelson, B. S., Fulenwider, H. D., Nennig, S. E., Smith, B. M., Sequeira, M. K., Chimberoff, S. H., Richie, C. T., Cheng, K., Rice, K. C., Harvey, B. K., et al. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.06.023 · Cited by 21
Smiley, C. E., McGonigal, J. T., Valvano, T., Newsom, R. J., Otero, N. K. H., & Gass, J. T. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05622-9 · Cited by 20
de Guevara‐Miranda, D. L., Pavón, F. J., Serrano, A., Rivera, P., Estivill‐Torrús, G., Suárez, J., de Fonseca, F. R., Santín, L. J., & Castilla‐Ortega, E. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.10.048 · Cited by 20
Sutherland, M. T., Carroll, A. J., Salmeron, B. J., Ross, T. J., Hong, L. E., & Stein, E. A. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.10.043 · Cited by 20
Scholl, J. L., Vuong, S. M., & Forster, G. L. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.07.008 · Cited by 20
Neuroscience of attentional processes for addiction medicine
Fadardi, J. S., Cox, W. M., & Rahmani, A. (2015) · Progress in brain research · doi:10.1016/bs.pbr.2015.08.002 · Cited by 20
O’Sullivan, S. J., & Schwaber, J. S. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.02.033 · Cited by 21
Kallupi, M., Oleata, C. S., Luu, G., Teshima, K., Ciccocioppo, R., & Roberto, M. (2014) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2014.00018 · Cited by 20
Ginsburg, B. C., & Lamb, R. J. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.09.016 · Cited by 20
Avegno, E. M., Kasten, C. R., Snyder, W. B., Kelley, L. K., Lobell, T. D., Templeton-Jager, T. J., Constans, M., Wills, T. A., Middleton, J. W., & Gilpin, N. W. (2020) · Addiction Biology · doi:10.1111/adb.12990 · Cited by 19
Hasler, B. (2024) · Alcohol research · doi:10.35946/arcr.v44.1.02 · Cited by 20
Ma, H., Wang, N., Wang, X., Jia, M., Li, Y., & Cui, C. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.10.032 · Cited by 20
Sampedro‐Piquero, P., Moreno‐Fernández, R. D., Begega, A., López, M., & Santín, L. J. (2022) · Addiction Biology · doi:10.1111/adb.13158 · Cited by 19
Cabral, D. A. R., Dongshi, W., Schuch, F. B., & Tavares, V. D. D. O. (2024) · Mental health and physical activity · doi:10.1016/j.mhpa.2024.100594 · Cited by 20
Metadata
- Authors
- Koob, G. F.
- Affiliations
- Scripps Research Institute (US)
- Corresponding author
- Koob, George F.
- ORCID
- Koob, George F.
- Venue
- Brain Research
- Publisher
- Elsevier BV
- Published
- 2009-10
- Volume
- 1293
- Pages
- 61-75
- ISSN
- 0006-8993 (ISSN-L)
- PMC
- PMC2774745
- OpenAlex
- W2010555262
- Cited by
- 388
- References
- 112
- Citations by year
- 2026: 11 · 2025: 10 · 2024: 22 · 2023: 17 · 2022: 20 · 2021: 24 · 2020: 31 · 2019: 33 · 2018: 34 · 2017: 20 · 2016: 25 · 2015: 28 · 2014: 24 · 2013: 24 · 2012: 20
- FWCI
- 1.88
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Brain Research (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute on Alcohol Abuse and Alcoholism (R01AA008459, AA-06420, AA-08459, P50AA006420, R37AA008459, P60AA006420)
- National Institute on Drug Abuse (DA04043, DA04398, R01DA004398, R01DA004043)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 26741, P01DK026741)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- drug addiction, extended amygdala, corticotropin-releasing factor, norepinephrine, central amygdala, bed nucleus of the stria terminalis, nucleus accumbens shell, negative reinforcement, emotional arousal, relapse, motivated behavior
- MeSH terms
- Amygdala, Animals, Compulsive Behavior, Corticotropin-Releasing Hormone, Humans, Hypothalamo-Hypophyseal System, Motivation, Norepinephrine, Pituitary-Adrenal System, Stress, Psychological, Substance Withdrawal Syndrome, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review